Clincosm LogoSign in Get a demo

Cancer

Showing NaN - NaN of 104
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cancer, NSCLC (NSCLC) Trial in Worldwide (Cofetuzumab Pelidotin)

Recruiting
  • Cancer
  • Non-small Cell Lung Cancer (NSCLC)
  • Cofetuzumab Pelidotin
  • Birmingham, Alabama
  • +25 more
Jan 31, 2023

Tumor, Tumor, Solid, Metastasis Trial in United States (nab-sirolimus)

Recruiting
  • Tumor
  • +20 more
  • Mobile, Alabama
  • +81 more
Jan 24, 2023

Cancer Trial in United States (SRK-181, anti-PD-(L)1 antibody therapy)

Recruiting
  • Cancer
  • SRK-181
  • anti-PD-(L)1 antibody therapy
  • Fullerton, California
  • +13 more
Jan 6, 2023

NSCLC, Anemia, Cancer Trial in Worldwide (Darbepoetin alfa, Placebo)

Terminated
Has Results
  • Non-Small Cell Lung Cancer
  • +3 more
  • Darbepoetin alfa
  • Placebo
  • Anniston, Alabama
  • +566 more
Nov 4, 2022

Cancer Trial in United States (VUMC telehealth services, Interview, Educational materials)

Recruiting
  • Cancer
  • VUMC telehealth services
  • +2 more
  • Columbus, Mississippi
  • +4 more
Nov 15, 2022

Cancer Trial in Nashville (EHR Nudge)

Recruiting
  • Cancer
  • EHR Nudge
  • Nashville, Tennessee
    Tennessee Oncology, PLLC
Nov 9, 2022

Advanced Malignancy, Advanced Solid Tumors, Cancer Trial in United States (AMG 337)

Completed
  • Advanced Malignancy
  • +5 more
  • AMG 337
  • Los Angeles, California
  • +7 more
Nov 3, 2022

Met Non Small Cell Cancer Registry (MOMENT)

Recruiting
  • Cancer
    • Fort Lauderdale, Florida
    • +53 more
    Nov 3, 2022

    Cancer, Chemo Trial in Nashville (Virtual reality therapy, Questionnaires, Measure heart rate)

    Recruiting
    • Cancer
    • Chemotherapy
    • Virtual reality therapy
    • +3 more
    • Nashville, Tennessee
      Vanderbilt-Ingram Cancer Center
    Sep 13, 2022

    Acute Myeloid Leukemia (AML), Cancer Trial in Worldwide (Venetoclax, Azacitidine, Best Supportive Care (BSC))

    Recruiting
    • Acute Myeloid Leukemia (AML)
    • Cancer
    • Scottsdale, Arizona
    • +169 more
    Aug 23, 2022

    Cancer Trial in Worldwide (Atezolizumab)

    Recruiting
    • Cancer
    • Birmingham, Alabama
    • +178 more
    Aug 17, 2022

    Cancer Trial in Torrance, Fort Wayne, Nashville (LY2503029, LY3023414)

    Available
    • Cancer
    • Torrance, California
    • +2 more
    Aug 17, 2022

    Cancer Trial in Worldwide (Nivolumab)

    Recruiting
    • Cancer
    • Lynwood, California
    • +253 more
    Aug 17, 2022

    Cancer Trial in Worldwide (Darolutamide (Nubeqa, BAY1841788))

    Recruiting
    • Cancer
    • Darolutamide (Nubeqa, BAY1841788)
    • Homewood, Alabama
    • +335 more
    Aug 8, 2022

    Cancer Trial in United States (TTX-080, pembrolizumab, cetuximab)

    Recruiting
    • Cancer
    • Tucson, Arizona
    • +33 more
    Aug 3, 2022

    Harbinger Health Test for Early Cancer Detection

    Recruiting
    • Cancer
    • Harbinger Health Test
    • Nashville, Tennessee
      HCA research Institute
    Jul 20, 2022

    Cancer Trial in United States (Survivorship Patient Navigation Intervention, Telehealth Survivorship Visit Intervention)

    Recruiting
    • Cancer
    • Survivorship Patient Navigation Intervention
    • Telehealth Survivorship Visit Intervention
    • Columbus, Mississippi
    • +3 more
    Jul 18, 2022

    Cancer, Solid Tumors Trial in United States (Vevorisertib, Fulvestrant, Paclitaxel)

    Terminated
    Has Results
    • Cancer
    • Solid Tumors
    • Las Vegas, Nevada
    • +5 more
    Jun 14, 2022

    Acute Myeloid Leukemia (AML), Cancer Trial in United States (venetoclax, azacytidine, decitabine)

    Completed
    • Acute Myeloid Leukemia (AML)
    • Cancer
    • Tempe, Arizona
    • +15 more
    Jun 10, 2022

    Cancer Trial in Worldwide (Dabrafenib, Trametinib)

    Completed
    • Cancer
    • Little Rock, Arkansas
    • +51 more
    Jun 8, 2022

    Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Acute Mixed-Phenotype Leukemia Trial in United States (BMF-219)

    Recruiting
    • Acute Myeloid Leukemia
    • +12 more
    • Los Angeles, California
    • +6 more
    Jun 1, 2022

    Oncology, Melanoma, Ovarian Cancer Trial in United States (E-602, Pembrolizumab)

    Recruiting
    • Oncology
    • +16 more
    • E-602
    • Pembrolizumab
    • Grand Rapids, Michigan
    • +4 more
    May 27, 2022

    Cancer Trial in Canada, United States (Vopratelimab, Ipilimumab)

    Active, not recruiting
    • Cancer
    • Beverly Hills, California
    • +20 more
    Apr 4, 2022

    Cause for Post-Transplant Diabetes Mellitus After Allogeneic

    Recruiting
    • Diabetes Mellitus
    • Cancer
    • Oral Glucose Tolerance Test (OGTT)
    • +2 more
    • Nashville, Tennessee
      Vanderbilt University Medical Center
    Mar 10, 2022

    Cancer, Tumors, Tumor Trial in Worldwide (BMS-986226, Nivolumab, Ipilimumab)

    Completed
    • Cancer
    • +3 more
    • Boston, Massachusetts
    • +12 more
    Mar 11, 2022